English
Bahasa Indonesia
简体中文
繁體中文
Tiếng Việt
OUR STORY
An offer of great hope,
transformative for all mankind
CELLAAX is a clinical-stage biopharmaceutical company specializing in the research, development, and commercialization of advanced regenerative medicine. Our core focus lies in cellular therapy—developing cutting-edge treatments that harness the body’s natural ability to heal, recover, and repair from diseases and injuries.
At CELLAAX, we adhere to the highest industry standards in the development of innovative human cell therapies and immunotherapies. Our success is driven by strategic collaborations with key stakeholders, ensuring that our advancements align with both the scientific community and market needs.
As a leader in regenerative medicine, CELLAAX is committed to transforming healthcare in Malaysia and Southeast Asia. Through continuous R&D efforts, we are expanding our portfolio of products, patents, and therapeutic protocols, positioning ourselves at the forefront of cellular therapy commercialization.
Vision
- To contribute to human welfare by application of biocellular engineering in research, development, and manufacture of cells to restore health and extend life.
- To direct our growth in the areas of biocellular engineering where we display maximum strength and ability; to gather people and facilities that tend to augment these areas; to continuously build on these areas through education and knowledge assimilation.
- To strive without reserve for the greatest possible reliability and quality; to be the unsurpassed standard of comparison and to be recognized as a company of dedication, honesty, integrity, and service.
MISSION
Create and deliver innovative healthcare solutions, developed in ethical collaboration with medical professionals, which enhance the quality of life for patients and improve outcomes for our customers and our shareholders.
Our focus as a team is to bring together
world class expertise in science, invention, innovation and investment
to accelerate the growth of human cell therapy in the region
Founder & CEO
ALEX WONG
As the revolution in medicine unfolds before us with ever developing new frontiers in human cell therapy treatments, CELLAAX is at the forefront of bringing hope and new possibilities to diseases, once incurable.
We genuinely believe in our mission to regenerate life around the world and extending life through our strong belief in the power of technology in biomedical engineering.
We have a diverse team of experts who serve the pledge of excellence in this frontier. The vast experiences, adaptability and medical retrospectives encourage us to strive without reserve for the greatest possible recognition in this industry. We hold each other accountable, act with integrity, and make quality of life our highest priority.
We welcome you to new possibilities and invite you to reimagine the future with us.
Founder & CEO
ALEX WONG
As the revolution in medicine unfolds before us with ever developing new frontiers in human cell therapy treatments, CELLAAX is at the forefront of bringing hope and new possibilities to diseases, once incurable.
We genuinely believe in our mission to regenerate life around the world and extending life through our strong belief in the power of technology in biomedical engineering.
We have a diverse team of experts who serve the pledge of excellence in this frontier. The vast experiences, adaptability and medical retrospectives encourage us to strive without reserve for the greatest possible recognition in this industry. We hold each other accountable, act with integrity, and make quality of life our highest priority.
We welcome you to new possibilities and invite you to reimagine the future with us.
Founder & Chief of Development Sciences
ANGELINA TIAH
The sudden outbreak of the COVID-19 virus sent the world into a global pandemic. Now more than ever, it has heightened our awareness on the importance of our health and overall being. Each of us were forced to rethink our health, as our quality of life depends highly on the state of it.
At CELLAAX , quality of life is what drives us. Throughout the course of the pandemic, our dedicated team of medical experts and scientists continued the research and development cell therapies and immunotherapies at our state-of-the-art cGMP laboratory here in the heart of Kuala Lumpur.
Our strategic alliance with 23 Century Life Science Center, who partner with Beike Biotechnology, the world’s largest stem cell producer based in Shenzhen, China have given us the push we need to expand the boundaries of healthcare and redefine what is and isn’t possible.
Keeping pace with this vigorous progress, CELLAAX is continuously updating our equipment and services in order to offer the latest and best services in high-tech medical care. Our recent developments include our patented drug to counter Retinitis Pigmentosa, a genetic defect which causes blindness.
These are one of the many milestones we celebrate here at CELLAAX , and with our continued efforts in research and development, we only see possibilities for a future of life changing outcomes.
Founder & Chief of Development Sciences
ANGELINA TIAH
The sudden outbreak of the COVID-19 virus sent the world into a global pandemic. Now more than ever, it has heightened our awareness on the importance of our health and overall being. Each of us were forced to rethink our health, as our quality of life depends highly on the state of it.
At CELLAAX, quality of life is what drives us. Throughout the course of the pandemic, our dedicated team of medical experts and scientists continued the research and development cell therapies and immunotherapies at our state-of-the-art cGMP laboratory here in the heart of Kuala Lumpur.
Our strategic alliance with 23 Century Life Science Center, who partner with Beike Biotechnology, the world’s largest stem cell producer based in Shenzhen, China have given us the push we need to expand the boundaries of healthcare and redefine what is and isn’t possible.
Keeping pace with this vigorous progress, CELLAAX is continuously updating our equipment and services in order to offer the latest and best services in high-tech medical care. Our recent developments include our patented drug to counter Retinitis Pigmentosa, a genetic defect which causes blindness.
These are one of the many milestones we celebrate here at CELLAAX, and with our continued efforts in research and development, we only see possibilities for a future of life changing outcomes.
We believe in collaborative partnership to bring you transformative solutions like never before